We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Distribution Agreement Expands Access to CE-Marked Precision Oncology Assays

By LabMedica International staff writers
Posted on 27 May 2026

Eurobio Scientific (Les Ulis, France) has signed a distribution agreement with Canhelp Genomics (Hangzhou, China) to broaden availability of the Canhelp‑UCa and Canhelp‑Origin assays. More...

The agreement extends distribution to France, Germany, the United Kingdom, Austria, Switzerland, and the Benelux region. It builds on the companies’ existing partnership in Italy to strengthen access to precision oncology testing.

Canhelp‑UCa is a CE‑marked IVD molecular assay developed for the noninvasive detection and recurrence monitoring of urothelial carcinoma of the bladder and upper urinary tract. The test analyzes an eight‑gene RNA signature from a urine sample to deliver molecular insights without invasive procedures. It is intended to support early detection in symptomatic patients and ongoing disease monitoring, helping reduce diagnostic uncertainty and enable timely clinical decisions.

Urothelial carcinoma is characterized by high recurrence rates and a significant burden of surveillance, often requiring repeated cystoscopies that can be uncomfortable and stressful for patients. In this setting, the UCa test provides a powerful complementary approach by enabling reliable detection through a convenient, non-invasive sample.

Canhelp‑Origin is a CE‑marked IVD assay for patients with cancer of unknown or uncertain primary, where standard evaluations cannot determine the site of origin. Using tumor tissue, the assay measures expression of 90 genes to generate a molecular profile that is compared with a reference database covering 21 tumor types to predict the most likely tissue of origin. By providing a data‑driven origin prediction, the test supports more targeted, site‑specific therapeutic decision‑making in complex metastatic presentations.

Cancer of unknown or uncertain primary is clinically challenging and can lead to empirical treatment approaches and poor prognosis. By providing a data-driven prediction of tumor origin, the Canhelp-Origin test helps clinicians move toward more targeted, site-specific therapies, even in complex metastatic cases where conventional diagnostics fail to identify the primary tumor. By reducing diagnostic uncertainty, the test supports more confident decision-making and a more personalized approach to cancer care.

Both assays are built on reverse transcription quantitative polymerase chain reaction (RT‑qPCR) technology for use on established laboratory platforms. They are compatible with the QuantStudio 5 Dx Real‑Time PCR system, the Applied Biosystems 7500 Real‑Time PCR system, and other RT‑qPCR instruments. The tests are designed for decentralized use, enabling testing closer to patients and supporting faster clinical decision‑making.

“We are delighted to partner with Canhelp Genomics to bring their advanced molecular diagnostic solutions to our markets,” said Denis Fortier, CEO of Eurobio Scientific. “These tests complement our existing oncology portfolio and support clinicians in making informed, precision-based treatment decisions.”

“The partnership with Eurobio Scientific is a defining moment in our mission to make precision oncology accessible to patients worldwide,” stated Dr. Qinghua Xu, CEO of Canhelp Genomics. “Eurobio Scientific’s proven expertise in molecular diagnostics commercialization and their extensive European network make them the ideal partner to bring our solutions to the clinicians and patients who need them most.”

Related Links
Eurobio Scientific
Canhelp Genomics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.